Hosted on MSN21d
GSK says asthma and nasal polyps therapy under EU review
an experimental monoclonal antibody targeting a class of cell signaling molecules called interleukin-5, for the treatment of asthma and nasal polyps. Submitting its Marketing Authorization ...
pharmaphorum4y
Sanofi/Regeneron on notice as FDA reviews GSK’s Nucala for nasal polyps
Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP ... The anti-IL-5 antibody is already approved by the FDA for severe ...
Hosted on MSN1mon
GSK’s Nucala approved in China as add-on therapy for adults with CRSwNP
a monoclonal antibody that targets interleukin-5, as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with chronic rhinosinusitis with nasal polyps ...
Science Daily15d
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The study included data on all Finnish adults with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery between January 2012 and December 2018, comprising a total of ...